Menu
Back to User profile » Dr Sha Zhao
Papers published by Dr Sha Zhao:
Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma
Wang H, Chen S, Meng D, Wu C, Zhu J, Jiang M, Ning J, Wu S, Wu L, Li J, Chen B, Zhao S, Li W, Yu J, Fang Q, Zhu J, Zhao W, He Y, Zhou C
OncoTargets and Therapy 2021, 14:2953-2965
Published Date: 4 May 2021
Single-Cell Sequencing, an Advanced Technology in Lung Cancer Research
Wang H, Meng D, Guo H, Sun C, Chen P, Jiang M, Xu Y, Yu J, Fang Q, Zhu J, Zhao W, Wu S, Zhao S, Li W, Chen B, Wang L, He Y
OncoTargets and Therapy 2021, 14:1895-1909
Published Date: 16 March 2021
Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer
Sun C, Zhang L, Zhang W, Liu Y, Chen B, Zhao S, Li W, Wang L, Ye L, Jia K, Wang H, Wu C, He Y, Zhou C
OncoTargets and Therapy 2020, 13:6475-6483
Published Date: 3 July 2020
OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
Deng J, Zhao S, Zhang X, Jia K, Wang H, Zhou C, He Y
OncoTargets and Therapy 2019, 12:7347-7353
Published Date: 6 September 2019
Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment
Wang H, Zhao S, Zhang X, Jia K, Deng J, Zhou C, He Y
OncoTargets and Therapy 2019, 12:7281-7288
Published Date: 5 September 2019
sLAG-3 in non-small-cell lung cancer patients’ serum
He Y, Wang Y, Zhao S, Zhao C, Zhou C, Hirsch FR
OncoTargets and Therapy 2018, 11:4781-4784
Published Date: 13 August 2018